...
首页> 外文期刊>BMJ: British medical journal >Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial
【24h】

Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial

机译:用益生菌乳酸杆菌治疗婴儿绞痛:双盲,安慰剂控制随机试验

获取原文
获取原文并翻译 | 示例
           

摘要

STUDY QUESTION: Does the probiotic Lactobacillus reuteri DSM 17938 reduce crying or fussing in a broad community based sample of both breastfed infants and formula fed infants aged less than 3 months with colic? SUMMARYANSWER: L reuteri DSM 17938 did not benefit a community sample of breastfed infants and formula fed infants with colic.WHAT IS KNOWN AND WHATTHIS PAPER ADDS: Previous small trials suggested that L reuteri effectively treats colic in breastfed infants; howeverthese studies had limitations, and the effect of the probiotic on formula fed infants with colic were unknown. L reuteri treatment did not reduce crying or fussing in infants with colic, nor was it effective in improving infant sleep, maternal mental health, family or infant functioning, or quality of life.
机译:研究问题:益生菌乳酸杆菌REUTERI DSM 17938是否会在母乳喂养的婴儿和配方奶粉中,在少于3个月的母乳喂养的婴儿和配方奶粉中减少了哭泣或大惊小怪? 摘要:L REUTERI DSM 17938并未使母乳喂养的婴儿和配方奶粉喂养婴儿的社区样本。这是已知的和纸质纸张的:先前的小型试验表明,L Reuteri有效地治疗母乳喂养婴儿的绞痛。 然而,这些研究有局限性,益生菌对绞痛婴儿的配方奶粉的影响尚不清楚。 L Reuteri治疗并没有减少绞痛婴儿的哭泣或大惊小怪,也没有有效改善婴儿睡眠,孕妇心理健康,家庭或婴儿功能或生活质量。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号